Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Gross Profit: 2021-2024

Historic Gross Profit for Solid Biosciences (SLDB) over the last 4 years, with Dec 2024 value amounting to -$340,000.

  • Solid Biosciences' Gross Profit rose 25.74% to -$75,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$340,000, marking a year-over-year increase of 22.55%. This contributed to the annual value of -$340,000 for FY2024, which is 22.73% up from last year.
  • As of FY2024, Solid Biosciences' Gross Profit stood at -$340,000, which was up 22.73% from -$440,000 recorded in FY2023.
  • In the past 5 years, Solid Biosciences' Gross Profit ranged from a high of $13.6 million in FY2021 and a low of -$440,000 during FY2023.
  • In the last 3 years, Solid Biosciences' Gross Profit had a median value of -$340,000 in 2024 and averaged $2.4 million.
  • Its Gross Profit has fluctuated over the past 5 years, first crashed by 105.44% in 2023, then climbed by 22.73% in 2024.
  • Solid Biosciences' Gross Profit (Yearly) stood at $13.6 million in 2021, then slumped by 40.57% to $8.1 million in 2022, then slumped by 105.44% to -$440,000 in 2023, then climbed by 22.73% to -$340,000 in 2024.